Recipharm, a global contract development and manufacturing organization (CDMO), and ProductLife Group (PLG), a global provider product development and regulatory affairs services, have joined forces to support (bio)pharmaceutical companies in accelerating time to clinical trials and market approval while reducing supply chain, compliance, and regulatory challenges during product development.

This agreement brings together Recipharm’s fully integrated development and manufacturing capabilities across small molecules, traditional biologics and advanced therapies medicinal products (ATMPs) with PLG’s expertise in product development, regulatory affairs and market access. By combining forces, the two companies will ensure customers receive comprehensive support from early-stage development to approval and market access, which will result in earlier availability of medicines to the market.

For Recipharm’s customers, the partnership offers immediate access to PLG’s product development expertise as well as their global regulatory affairs, pharmacovigilance and market access experience. For PLG’s clients, the collaboration opens access to Recipharm’s manufacturing infrastructure, including integrated and intelligent development, manufacturing support for faster and more cost-effective development, and predictive models for biologics production and release, offering a high-value solution tailored to global needs.

Greg Behar, Recipharm’s CEO, explains: “This partnership brings together Recipharm’s development and manufacturing expertise, with PLG’s 2,000 regulatory experts, operating across 150 countries. By integrating scientific, regulatory, operational and commercial strategy from the outset, we help our customers move faster, avoid costly delays and build confidence that their product submissions will meet and exceed agency requirements for critical medicines worldwide.”

Xavier Duburcq, PLG’s CEO, adds: “As regulatory complexity grows, our clients need integrated solutions that connect strategy and execution. With Recipharm’s 700 product development experts and over 400 projects delivered annually, this partnership allows us to embed regulatory thinking directly into product development and operational planning. Together, we help our clients ensure compliance and build stronger submissions from the start.”